1. Home
  2. CGEM vs SSTK Comparison

CGEM vs SSTK Comparison

Compare CGEM & SSTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cullinan Oncology Inc.

CGEM

Cullinan Oncology Inc.

HOLD

Current Price

$12.37

Market Cap

671.7M

Sector

Health Care

ML Signal

HOLD

Logo Shutterstock Inc.

SSTK

Shutterstock Inc.

HOLD

Current Price

$18.09

Market Cap

675.2M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
CGEM
SSTK
Founded
2016
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
671.7M
675.2M
IPO Year
2021
2012

Fundamental Metrics

Financial Performance
Metric
CGEM
SSTK
Price
$12.37
$18.09
Analyst Decision
Strong Buy
Buy
Analyst Count
8
2
Target Price
$28.00
$25.00
AVG Volume (30 Days)
1.3M
179.3K
Earning Date
11-06-2025
11-05-2025
Dividend Yield
N/A
7.30%
EPS Growth
N/A
66.87
EPS
N/A
1.69
Revenue
N/A
$1,020,010,000.00
Revenue This Year
N/A
$11.41
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$10.73
Revenue Growth
N/A
13.06
52 Week Low
$5.68
$14.35
52 Week High
$13.60
$38.80

Technical Indicators

Market Signals
Indicator
CGEM
SSTK
Relative Strength Index (RSI) 67.30 31.14
Support Level $10.01 $19.72
Resistance Level $13.33 $21.68
Average True Range (ATR) 1.21 0.78
MACD 0.12 -0.16
Stochastic Oscillator 81.18 2.37

Price Performance

Historical Comparison
CGEM
SSTK

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

About SSTK Shutterstock Inc.

Shutterstock Inc is a U.S.-based company that is engaged in the provision of digital content. The content segment, whose offerings include licenses for Images, Footage, Music, 3 Dimensional, and Generative AI content. Data, Distribution, and Service offerings address customer demand for products and services that are beyond its Content licenses. The company generates the majority of its revenue from Content offerings. Geographically the company generates the majority of its revenue from the Domestic market, but also has its presence in Europe and Rest of the Countries.

Share on Social Networks: